Behind the buying is news that the Senate is pushing forward legislation that would end the U.S. government shutdown.

History is on the side of the financial sector with the prospect of additional rate cuts to come. This could provide the perfect investment opportunity for an active ETF like the Fidelity Disruptive Finance ETF (FDFF).

GREEN BAY, Wis.--(BUSINESS WIRE)--Schneider National, Inc. (NYSE: SNDR), a premier multimodal provider of transportation, intermodal and logistics services, is introducing Schneider Fast Track, a premium solution designed for shippers with time-sensitive and high-service freight needs. Fast Track combines Schneider's extensive asset-based truckload and intermodal capabilities with strategic rail partnerships to create a network of some of the fastest, most consistent intermodal lanes in the ind.

The JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) stands out as a high-quality covered call ETF with a robust 10% yield at current prices. JEPQ's total returns have been compelling, and its price upside is less capped compared to other covered call ETFs, making it attractive for investors. Rising market volatility could further benefit JEPQ, as higher option premiums would likely boost dividends for shareholders.

ARS Pharmaceuticals, Inc. delivered strong Q3 Neffy sales, doubling sequentially, but remains unprofitable with high SG&A expenses and no 2026 guidance. SPRY faces competitive threats from generics and upcoming alternatives, but patent litigation could delay generic Neffy entry until 2039. Neffy's needle-free, lower-cost profile is driving adoption, with growing prescriber base and international launches, but long-term profitability remains uncertain.

Oil traders are not ready for big moves amid lack of strong catalysts.

New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

Alphabet's self-driving car unit Waymo appointed a new CFO Monday. The company tapped Google finance executive Steve Fieler.

The ‘Big Oil' quarterly earnings season ended last week, as one energy major after another posted relatively lower profits compared to bumper ones from three years ago. But there was one other commonality between them all - a clear and firm return to oil and gas basics.

The sale comes as private-equity firms are increasing investment in the aerospace and defense sector.

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public.

The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - are currently fairly priced, with annual dividends from $1,000 invested meeting or exceeding share prices. Analyst forecasts suggest top-yielding Kings could deliver net gains of 18.55% to 101.43% by November 2026, with Stepan, H2O America, and National Fuel Gas among the top projections.

Incyte Corporation ( INCY ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 10:00 AM EST Company Participants William Meury - CEO, President & Director Pablo Cagnoni - President and Head of Research & Development Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division All right. So welcome to this fireside chat with Incyte.

New management continues to execute the Goodyear Forward Plan. U.S. trade policies provide Goodyear with a competitive financial advantage over international rivals. Temporary issues hinder the operating margins of the industry.

Outlines Key Initiatives to Reverse Chronic Underperformance, Restore Investor Confidence, Improve Governance, and Drive Value Creation at Cannae

Tesla board chair Robyn Denholm thanked the electric-vehicle maker's shareholders on Monday for approving CEO Elon Musk's $878 billion pay package.

The agreement would allow merchants to lower fees and reject certain credit cards. But what does it mean for the stocks—and shoppers.

New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Prominent shareholder rights law firm Hagens Berman is investigating Stride, Inc. (NYSE: LRN), the online education platform, for potential violations of the U.S. securities laws following a series of negative market events and serious fraud allegations that have seen the company's stock price plummet. The firm urges investors in Stride who suffered significant losses to submit your losses now.

Exelixis, Inc. ( EXEL ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 10:30 AM EST Company Participants Michael Morrissey - CEO, President & Director Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division Welcome to this next fireside chat with Exelixis. With us today, we have Mike Morrissey, President and CEO.